We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RDC market cap is 1.99B. The company's latest EPS is EUR -0.6616 and P/E is -181.83.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 701.01M | 968.06M | 1.06B | 1.2B | 1.8B |
| Operating Income | -33.34M | -821k | -66.13M | -68.83M | -17.07M |
| Net Income | -36.27M | -16.77M | -74.19M | -77.65M | -12.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 427.98M | 536.91M | 783.08M | 729.47M | 1.02B |
| Total Liabilities | 195.22M | 111.77M | 367.66M | 374.84M | 469.56M |
| Total Equity | 232.76M | 425.14M | 415.41M | 354.63M | 552.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -30.37M | 17.8M | 11.64M | -29.11M | 61.46M |
| Investing | -33.4M | -40.26M | -84.3M | -138.01M | -59.96M |
| Financing | 102.08M | 50.29M | 229.59M | -13.52M | 15.05M |
| Market Cap | 1.99B |
| Price to Earnings Ratio | -181.83 |
| Price to Sales Ratio | 1.22 |
| Price to Cash Ratio | 26.01 |
| Price to Book Ratio | 3.97 |
| Dividend Yield | - |
| Shares Outstanding | 18.2M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.8 (0.73%) |
| Company Name | Redcare Pharmacy NV |
| Address |
erik de rodeweg 11/13 venlo, limburg 5975 WD |
| Website | https://www.redcare-pharmacy.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
